90 related articles for article (PubMed ID: 16146045)
21. Treatment with atorvastatin partially protects the rat heart from harmful catecholamine effects.
Schmechel A; Grimm M; El-Armouche A; Höppner G; Schwoerer AP; Ehmke H; Eschenhagen T
Cardiovasc Res; 2009 Apr; 82(1):100-6. PubMed ID: 19136528
[TBL] [Abstract][Full Text] [Related]
22. [Effects of tripterygium glycoside on apoptosis of the skeletal muscle after nerve allograft].
Huang Y; Jiang D; Chen L; Jiang H
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Jan; 23(1):101-5. PubMed ID: 19192890
[TBL] [Abstract][Full Text] [Related]
23. Statins induce differentiation and cell death in neurons and astroglia.
März P; Otten U; Miserez AR
Glia; 2007 Jan; 55(1):1-12. PubMed ID: 16998865
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia.
Lee SH; Chung N; Kwan J; Kim DI; Kim WH; Kim CJ; Kim HS; Park SH; Seo HS; Shin DG; Shin YW; Shim WJ; Ahn TH; Ho Yun K; Yoon MH; Cha KS; Choi SW; Han SW; Hyon MS
Clin Ther; 2007 Nov; 29(11):2365-73. PubMed ID: 18158077
[TBL] [Abstract][Full Text] [Related]
25. L-arginine plus atorvastatin for prevention of atheroma formation in genetically hypercholesterolaemic rabbits.
Rasmusen C; Moinard C; Martin C; Tricottet V; Cynober L; Couderc R
Br J Nutr; 2007 Jun; 97(6):1083-9. PubMed ID: 17391569
[TBL] [Abstract][Full Text] [Related]
26. Hepatoselectivity of statins: design and synthesis of 4-sulfamoyl pyrroles as HMG-CoA reductase inhibitors.
Park WK; Kennedy RM; Larsen SD; Miller S; Roth BD; Song Y; Steinbaugh BA; Sun K; Tait BD; Kowala MC; Trivedi BK; Auerbach B; Askew V; Dillon L; Hanselman JC; Lin Z; Lu GH; Robertson A; Sekerke C
Bioorg Med Chem Lett; 2008 Feb; 18(3):1151-6. PubMed ID: 18155906
[TBL] [Abstract][Full Text] [Related]
27. Atorvastatin ameliorates tubulointerstitial fibrosis and protects renal function in chronic partial ureteral obstruction cases.
Fitzgerald JP; Chou SY; Franco I; Mooppan UM; Kim H; Saini R; Gulmi FA
J Urol; 2009 Oct; 182(4 Suppl):1860-8. PubMed ID: 19692013
[TBL] [Abstract][Full Text] [Related]
28. The HMG-CoA reductase inhibitor, atorvastatin, attenuates the effects of acute administration of amyloid-beta1-42 in the rat hippocampus in vivo.
Clarke RM; O'Connell F; Lyons A; Lynch MA
Neuropharmacology; 2007 Jan; 52(1):136-45. PubMed ID: 16920163
[TBL] [Abstract][Full Text] [Related]
29. Anti-atherosclerotic effect of atorvastatin and clopidogrel alone and in combination in rats.
Srinivas M; Annapurna A; Reddy YN
Indian J Exp Biol; 2008 Oct; 46(10):698-703. PubMed ID: 19024167
[TBL] [Abstract][Full Text] [Related]
30. Systemic evaluation of gene expression changes in major target organs induced by atorvastatin.
Kato N; Liang YQ; Ochiai Y; Jesmin S
Eur J Pharmacol; 2008 Apr; 584(2-3):376-89. PubMed ID: 18295756
[TBL] [Abstract][Full Text] [Related]
31. Atorvastatin reduces oxidative stress in the rostral ventrolateral medulla of stroke-prone spontaneously hypertensive rats.
Kishi T; Hirooka Y; Shimokawa H; Takeshita A; Sunagawa K
Clin Exp Hypertens; 2008 Jan; 30(1):3-11. PubMed ID: 18214729
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of laser-induced choroidal neovascularization by atorvastatin by downregulation of monocyte chemotactic protein-1 synthesis in mice.
Yamada K; Sakurai E; Itaya M; Yamasaki S; Ogura Y
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1839-43. PubMed ID: 17389519
[TBL] [Abstract][Full Text] [Related]
33. Atorvastatin donor pretreatment prevents ischemia/reperfusion injury in renal transplantation in rats: possible role for aldose-reductase inhibition.
Gottmann U; Brinkkoetter PT; Hoeger S; Gutermann K; Coutinho ZM; Ruf T; Hui S; Liu Z; Schnuelle P; van der Woude FJ; Braun C; Yard BA
Transplantation; 2007 Sep; 84(6):755-62. PubMed ID: 17893609
[TBL] [Abstract][Full Text] [Related]
34. Attenuation of contractile dysfunction by atorvastatin after intestinal ischemia reperfusion injury in rats.
Ozacmak VH; Sayan H; Igdem AA; Cetin A; Ozacmak ID
Eur J Pharmacol; 2007 May; 562(1-2):138-47. PubMed ID: 17335801
[TBL] [Abstract][Full Text] [Related]
35. Light and electron microscope examination of the effects of methotrexate on the endosalpinx.
Bayram M; Ozogul C; Dursun A; Ercan ZS; Isik I; Dilekoz E
Eur J Obstet Gynecol Reprod Biol; 2005 May; 120(1):96-103. PubMed ID: 15866094
[TBL] [Abstract][Full Text] [Related]
36. Effect of atorvastatin on energy expenditure and skeletal muscle oxidative metabolism at rest and during exercise.
Chung J; Brass EP; Ulrich RG; Hiatt WR
Clin Pharmacol Ther; 2008 Feb; 83(2):243-50. PubMed ID: 17554242
[TBL] [Abstract][Full Text] [Related]
37. Atorvastatin but not elocalcitol increases sildenafil responsiveness in spontaneously hypertensive rats by regulating the RhoA/ROCK pathway.
Fibbi B; Morelli A; Marini M; Zhang XH; Mancina R; Vignozzi L; Filippi S; Chavalmane A; Silvestrini E; Colli E; Adorini L; Vannelli GB; Maggi M
J Androl; 2008; 29(1):70-84. PubMed ID: 17699803
[TBL] [Abstract][Full Text] [Related]
38. HMG-CoA reductase inhibition improves anti-aging klotho protein expression and arteriosclerosis in rats with chronic inhibition of nitric oxide synthesis.
Kuwahara N; Sasaki S; Kobara M; Nakata T; Tatsumi T; Irie H; Narumiya H; Hatta T; Takeda K; Matsubara H; Hushiki S
Int J Cardiol; 2008 Jan; 123(2):84-90. PubMed ID: 17434618
[TBL] [Abstract][Full Text] [Related]
39. Biphasic effects of atorvastatin on inflammation.
Garjani A; Andalib S; Ziaee M; Maleki-Dizaji N
Pak J Pharm Sci; 2008 Apr; 21(2):125-30. PubMed ID: 18390442
[TBL] [Abstract][Full Text] [Related]
40. Atorvastatin inhibits renal crystal retention in a rat stone forming model.
Tsujihata M; Momohara C; Yoshioka I; Tsujimura A; Nonomura N; Okuyama A
J Urol; 2008 Nov; 180(5):2212-7. PubMed ID: 18804815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
